We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current SGHT market cap is 190.84M. The company's latest EPS is USD -1.0944 and P/E is -3.44.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 23.47M | 20.01M | 18.75M | 19.27M | 21.37M |
| Operating Income | -15.19M | -13.41M | -11.11M | -14.72M | -12.65M |
| Net Income | -14.75M | -13.04M | -10.69M | -16.27M | -12.33M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 23.35M | 27.64M | 48.96M | 71.33M | 81.06M |
| Operating Income | -24.04M | -32.19M | -51.48M | -83.95M | -57.27M |
| Net Income | -25.87M | -34.69M | -62.96M | -86.24M | -55.55M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 185.29M | 176.64M | 166.65M | 155.56M | 149.72M |
| Total Liabilities | 49.16M | 49.57M | 46.44M | 46.35M | 48.08M |
| Total Equity | 136.13M | 127.07M | 120.22M | 109.21M | 101.64M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 30.74M | 72.81M | 280.19M | 213.07M | 166.65M |
| Total Liabilities | 21.17M | 44.32M | 48.08M | 53M | 46.44M |
| Total Equity | -54.68M | -88.85M | 232.11M | 160.08M | 120.22M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -30.87M | -40.7M | -47.18M | -9.79M | -19.25M |
| Investing | -223k | -527k | -791k | -117k | -197k |
| Financing | 610k | 728k | 1.1M | -942k | -501k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -25M | -32.17M | -52.54M | -75.97M | -47.18M |
| Investing | -672k | -953k | -813k | -970k | -791k |
| Financing | 42.66M | 73.4M | 252.53M | 1.25M | 1.1M |
| Market Cap | 190.84M |
| Price to Earnings Ratio | -3.44 |
| Price to Sales Ratio | 2.35 |
| Price to Cash Ratio | 1.38 |
| Price to Book Ratio | 1.59 |
| Dividend Yield | - |
| Shares Outstanding | 50.75M |
| Average Volume (1 week) | 251.65k |
| Average Volume (1 Month) | 264.72k |
| 52 Week Change | 54.73% |
| 52 Week High | 8.45 |
| 52 Week Low | 2.28 |
| Spread (Intraday) | 0.53 (13.15%) |
| Company Name | Sight Sciences Inc |
| Address |
850 new burton road dover, delaware 19904 |
| Website | https://www.sightsciences.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
